July 7, 2020 / 1:44 PM / a month ago

BRIEF-Curis Says Doses First Patient In Phase 1 Study Of CA-4948 In Patients With Acute Myeloid Leukemia And Myelodysplastic Syndromes

July 7 (Reuters) - Curis Inc:

* CURIS DOSES FIRST PATIENT IN PHASE 1 STUDY OF CA-4948 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

* CURIS INC - INITIAL DATA EXPECTED IN Q4 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below